UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

The New England journal of medicine, 2020-10, Vol.383 (15), p.1425-1435

2020

Volltextzugriff (PDF)

Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study

Diabetes & metabolism, 2015-04, Vol.41 (2), p.116-125

2015

Volltextzugriff (PDF)

Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal

Diabetes & metabolism, 2014-06, Vol.40 (3), p.176-185

2014

Volltextzugriff (PDF)

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

Diabetic medicine, 2005-04, Vol.22 (4), p.399-405

2005

Volltextzugriff (PDF)

After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?

Diabetes & metabolism, 2017-04, Vol.43, p.2S3-2S12

2017

Volltextzugriff (PDF)

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings

Diabetes & metabolism, 2019-12, Vol.45 (6), p.528-535

2019

Volltextzugriff (PDF)

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

European heart journal, 2007-01, Vol.28 (1), p.88-136

2007

Volltextzugriff (PDF)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes

Diabetes & metabolism, 2020-04, Vol.46 (2), p.110-118

2020

Volltextzugriff (PDF)

Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial

The journal of clinical endocrinology and metabolism, 2004-12, Vol.89 (12), p.6068-6076

2004

Volltextzugriff (PDF)

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study

Diabetes/metabolism research and reviews, 2005-03, Vol.21 (2), p.167-174

2005

Volltextzugriff (PDF)

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

Diabetologia, 2013-07, Vol.56 (7), p.1503-1511

2013

Volltextzugriff (PDF)

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Diabetologia, 2010-07, Vol.53 (7), p.1258-1269

2010

Volltextzugriff (PDF)

Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes

International journal of clinical practice (Esher), 2007-06, Vol.61 (s153), p.1-2

Charbonnel, B.

2007

Volltextzugriff (PDF)

CA-109: Conséquences d'une hypoglycémie sévère sur le contrôle glycémique dans le diabète : analyse du DCCT

Diabetes & metabolism, 2016-03, Vol.42, p.A64-A65

2016

Volltextzugriff (PDF)

Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes

Diabetes & metabolism, 2017-09, Vol.43 (4), p.392-394

2017

Volltextzugriff (PDF)

Insulin therapy for diabetes mellitus: Treatment regimens and associated costs

Diabetes & metabolism, 2012-04, Vol.38 (2), p.156-163

2012

Volltextzugriff (PDF)

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues

Diabetes research and clinical practice, 2016-06, Vol.116, p.26-28

2016

Volltextzugriff (PDF)

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

Diabetologia, 2005-06, Vol.48 (6), p.1093-1104

2005

Volltextzugriff (PDF)

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study

Diabetes & metabolism, 2003-12, Vol.29 (6), p.587-594

2003

Volltextzugriff (PDF)

CA-117: L'hypoglycémie est-elle un risque modifiable chez les diabétiques de type 2 (DT2) ? Analyse des essais cliniques de l'insuline glargine 300 U/mL (Gla-300) vs 100 U/mL (Gla-100) en fonction du risque d'hypoglycémies à répétition

Diabetes & metabolism, 2016-03, Vol.42, p.A67-A67

2016

Volltextzugriff (PDF)

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?

Diabetes research and clinical practice, 2016-06, Vol.116, p.26-28

2016

Volltextzugriff (PDF)

What a psychiatrist needs to know about diabetes

European psychiatry, 2005-12, Vol.20 (S4), p.S330-S334

Charbonnel, B.

2005

Volltextzugriff (PDF)

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)

Diabetic medicine, 2009-10, Vol.26 (10), p.1033-1039

2009

Volltextzugriff (PDF)

Fulminant type 1 diabetes in Caucasians: A report of three cases

Diabetes & metabolism, 2008-11, Vol.34 (5), p.529-532

2008

Volltextzugriff (PDF)

Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial

Diabetes & metabolism, 2017-04, Vol.43 (2), p.187-190

2017

Volltextzugriff (PDF)

1 – 25 von 441

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(313)

Publikationsform

Sprache

Englisch
(266)
Französisch
(176)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(190)
Science & Technology
(166)
Life Sciences & Biomedicine
(142)
Female
(116)
Male
(95)
Endocrinology & Metabolism
(94)
Adult
(92)
Biological And Medical Sciences
(89)
Medical Sciences
(79)
Endocrinopathies
(74)
Middle Aged
(72)
Aged
(53)
Endocrine Pancreas. Apud Cells
(45)
Diabetes. Impaired Glucose Tolerance
(44)
Sciences Biologiques Et Medicales
(42)
Sciences Medicales
(42)
Internal Medicine
(40)
Hypoglycemic Agents - Therapeutic Use
(39)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(35)
Diabetes Mellitus, Type 2 - Drug Therapy
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study

Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists?

Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes

Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes

CA-109: Conséquences d'une hypoglycémie sévère sur le contrôle glycémique dans le diabète : analyse du DCCT

Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes

Insulin therapy for diabetes mellitus: Treatment regimens and associated costs

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study

CA-117: L'hypoglycémie est-elle un risque modifiable chez les diabétiques de type 2 (DT2) ? Analyse des essais cliniques de l'insuline glargine 300 U/mL (Gla-300) vs 100 U/mL (Gla-100) en fonction du risque d'hypoglycémies à répétition

Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?

What a psychiatrist needs to know about diabetes

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)

Fulminant type 1 diabetes in Caucasians: A report of three cases

Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial

Aktive Filter

Suchergebnisse filtern